Remember me
Lessons Learned from a review of FDA PRO Labeling (2010 – 2015)

Listen in as our experts in patient-centered outcomes and market access strategy have a conversation about their analysis of FDA PRO labeling over the last ten years. They will cover what you need to know as you gather evidence about your product, and answer your questions about PRO labeling strategy.


What you will learn:

1. Trends in PRO labeling over the past 10 years

2. Types of measures used for PRO labels

3. Diseases for which PRO labeling is facilitated

4. Examples of successes and failures, and the lessons we've learned


Event Registration

To start registration, please enter your details below and click Continue.

Register Now
Registration is Free
Carla DeMuro, MS
Executive Director, Patient-Centered Outcomes Assessment
Ari Gnanasakthy, MBA, MSc
Principal Scientist, Patient-Centered Outcomes Assessment
Margaret Mordin, MS
Senior Director, Market Access and Outcomes Strategy